Lantheus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

Lantheus (NASDAQ: LNTH) announced that Vice President of External Manufacturing John Wiggins will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference at 8:40 a.m. ET on Tuesday, June 9.

Rhea-AI Summary

Lantheus (NASDAQ: LNTH) announced that Vice President of External Manufacturing John Wiggins will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference at 8:40 a.m. ET on Tuesday, June 9. A live webcast and 30-day replay will be available on the company’s investor website.

Argus Jun 3 session

+4.10% close to close Open Argus

Details

News Market Reaction – LNTH

In the Jun 3 session, LNTH gained 4.10%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights Lantheus’ participation in a Goldman Sachs healthcare conference, with ...

Analysis

This announcement highlights Lantheus’ participation in a Goldman Sachs healthcare conference, with an 8:40 a.m. ET fireside chat and a webcast replay for at least 30 days. It reinforces ongoing investor outreach rather than introducing new financial or clinical data. Recent history shows more meaningful market responses to earnings and regulatory milestones than to conference logistics. Investors monitoring this name may focus on future data readouts, financial results, and regulatory events as clearer catalysts.

Key Figures

Conference edition: 47th Annual Presentation time: 8:40 a.m. ET Webcast replay period: 30 days

Conference edition

47th Annual

Goldman Sachs Global Healthcare Conference

Presentation time

8:40 a.m. ET

Time of fireside chat on June 9

Webcast replay period

30 days

Replay available on company website after presentation

Historical Context

5 past events · Latest: May 27

5 events

1. May 27

   Investor conference

   24h Move

   -1.0%

   Announcement of William Blair fireside chat and webcast access details.

2. May 21

   Clinical data update

   24h Move

   -1.7%

   New radiodiagnostic data presentations at the 2026 SNMMI Annual Meeting.

3. May 19

   Clinical data update

   24h Move

   -0.6%

   Radiopharmaceutical data presentations at the 2026 ASCO Annual Meeting.

4. May 07

   Earnings and approvals

   24h Move

   +5.6%

   Q1 2026 results with strong EPS, FDA approval and reaffirmed guidance.

5. Apr 23

   Earnings call notice

   24h Move

   -0.1%

   Scheduling of Q1 2026 earnings call and webcast information.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

radiopharmaceutical-focused

1 terms

radiopharmaceutical-focused medical

"the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow"

An organization described as radiopharmaceutical-focused develops or markets drugs that carry tiny amounts of radioactive material to detect, image, or treat disease; think of them as companies making guided medical ‘beacons’ or targeted missiles that find and act on diseased tissue. That focus matters to investors because it shapes a company’s growth prospects, regulatory hurdles, specialized manufacturing needs, and potential for high-value, niche revenue streams tied to medical adoption and reimbursement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BEDFORD, Mass., June 03, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver better patient outcomes, today announced John Wiggins, Vice President, External Manufacturing, will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference at 8:40 a.m. ET on Tuesday, June 9.

To access the live webcast of the presentations, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcasts will be available on the Company’s website for at least 30 days following the live presentation.

About Lantheus

Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada, Germany, Sweden, Switzerland, and the United Kingdom, Lantheus has been providing radiopharmaceutical solutions for 70 years. For more information, visit www.lantheus.com.

Contacts:

Mark Kinarney
Vice President, Investor Relations
978-671-8842
ir@lantheus.com

Melissa Downs
Executive Director, External Communications
646-975-2533
media@lantheus.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Lantheus (NASDAQ: LNTH) present at the Goldman Sachs 47th Annual Global Healthcare Conference?

Lantheus will present at the Goldman Sachs 47th Annual Global Healthcare Conference at 8:40 a.m. ET on Tuesday, June 9. According to Lantheus, Vice President John Wiggins will join a fireside chat session for investors and stakeholders.

Who is representing Lantheus (LNTH) at the Goldman Sachs 47th Annual Global Healthcare Conference?

Lantheus will be represented by John Wiggins, Vice President of External Manufacturing. According to Lantheus, Wiggins will participate in a fireside chat, offering insights on the company’s radiopharmaceutical-focused business to investors attending the Goldman Sachs healthcare conference.

How can investors access the Lantheus (LNTH) webcast from the Goldman Sachs healthcare conference?

Investors can access the Lantheus webcast by visiting the Investors section of the company’s website. According to Lantheus, the live fireside chat from the Goldman Sachs 47th Annual Global Healthcare Conference will stream there at the scheduled time.

Will a replay of Lantheus (LNTH) presentation at the Goldman Sachs healthcare conference be available?

Yes, a replay of the Lantheus conference presentation will be available. According to Lantheus, investors can access the archived webcast on the company’s website for at least 30 days following the live Goldman Sachs 47th Annual Global Healthcare Conference session.

What type of session will Lantheus (LNTH) hold at the Goldman Sachs 47th Annual Global Healthcare Conference?

Lantheus will participate in a fireside chat session at the Goldman Sachs 47th Annual Global Healthcare Conference. According to Lantheus, Vice President John Wiggins will discuss the company’s radiopharmaceutical-focused operations with conference attendees and online viewers.